PAXMAN continues the fight against chemotherapy hair loss

6 months ago | News

HAIR loss is one of the most feared side effects of chemotherapy and often people will refuse treatment because they don’t want to lose their hair. The damage that chemotherapy causes to the hair follicle can be alleviated by using the scalp cooling treatment, also known as the 'cold cap'.

Scalp cooling expert and Made in Britain member, PAXMAN has launched its latest model with an interactive user interface and touchscreen ensuring ease of use for clinical staff. Maintaining coolant levels is also simplified by a visual warning system display and an easy-to-use self-drain coolant refill bag.

The new control pump manages the speed and coolant flow, improving the consistency of treatment. Manufacturing technique changes have also been introduced – the front cover of the scalp cooling machine is now injection moulded rather than RIM moulded – to improve the overall aesthetics of the system.

These changes incorporate the latest research, product design and testing carried out by the University of Huddersfield to ensure PAXMAN are at the forefront of innovation. It follows the recent re-design of the silicone cooling cap, which was introduced to ensure the cap fitted patients’ heads more effectively.

CEO Richard Paxman said, “Over the years we have invested heavily in new R&D, funding multi-disciplinary research groups and conducting clinical trials to help improve the efficiency of scalp cooling. Ultimately it is our aim to raise the success rate of ‘zero hair loss’ from 50:50 to 80:20 by 2020 and we are committed to working with scientists, oncologists, patients and hospitals around the globe to achieve this.”

For more information visit www.paxmanscalpcooling.com or check out the company’s Made in Britain member profile

Back to News

Share this page: